Study Group: Biotechnology Patent Experts: Lawyers (US)

Council Members in this Study Group: 98

This study group may include professors, attorneys, former regulatory officers, and consultants knowledgeable on topics such as law and litigation issues, lobbying, policy and government, elections, antitrust, immigration, intellectual property, and legislation, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Steven Jenning, Principal, CAPITOL HEALTH GROUP, LLCSteven Jenning

Principal
CAPITOL HEALTH GROUP, LLC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Steven Jenning is Principal at Capitol Health Group in Washington, DC, where he specializes in federal health care legislation, policy and regulation. Mr. Jenning covers a broad range of health care issues, including prescription drug benefits and pricing,...

3 event(s)
Michael McNeely

Principal
Law Offices of Michael D. McNeely
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Michael McNeely is in private practice in Washington, DC, where he provides antitrust counseling and representation. Mr. McNeely consults on the antitrust and antitrust agency aspects of mergers, generic drug approvals, telecommunications, patents, standard...

Stephen Bent, Partner, FOLEY & LARDNER LLPStephen Bent

Partner
FOLEY & LARDNER LLP
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Stephen A. Bent is Partner and former co-leader of the Life Sciences Industry Team at Foley & Lardner in Washington, DC. He is also a member of the Biotechnology & Pharmaceutical Practice Group and the Health Care and Nanotechnology Industry Teams. Mr....

Thomas Saunders, Of Counsel, RISSMAN HENDRICKS & OLIVERIO, LLPThomas Saunders

Of Counsel
RISSMAN HENDRICKS & OLIVERIO, LLP
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Thomas Saunders is an Of Counsel at Rissman Hendricks & Oliverio. He specializes in representing emerging medical technology, biotechnology/genetic engineering and pharmaceutical concerns, particularly as to patent prosecution, patent strategy, IP licensing...

2 news post(s)
Marc Scheineson, Partner & Chair, Food and Drug Practice, ALSTON & BIRD LLPMarc Scheineson

Partner & Chair, Food and Drug Practice
ALSTON & BIRD LLP
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Marc Scheineson is a Partner with Alston & Bird where he heads the firm's Food and Drug Law Practice. He has practiced food and drug law, health care law, and administrative law for over 20 years in national law firms and at the FDA. His practice focuses...

View all Leading Experts in this Study Group

Join this Study Group

Members in this Study Group include these company types:

  • Law Firm (general practice/large)
  • Law Firm (Boutique / Specialized)
  • Law firm (small / solo)
  • Pharmaceuticals Manufacturer

Members in this Study Group often have these job titles:

  • Partner
  • Patent and Intellectual Property Law
  • Attorney
  • Legal Counsel
  • Principal

Related Study Groups

Study Group Name No. Members
Medical Devices Experts: Lawyers (US) 24
Generic Drug Economic Experts 890
FERC Nuclear Experts: Lawyers 12
Intellectual Property Experts: Lawyers (US) 140
Pharmaceutical Regulation and FDA Experts: Lawyers 48
FDA Medical Device Experts: Lawyers 30
Hardware / Network Experts: Lawyers (US) 13
FTC Healthcare M&A Experts: Lawyers 14

GLG Live Meetings with this Study Group's Leading Experts (?)

March 11, 2009 | Boston

GLG Seminar: (BOS) Obama Budget - A Road Map for Healthcare Reform with Steve Jenning

November 1, 2007 | New York

GLGi: Big Pharma v. Generics - Science Patent Battles

August 25, 2006 | New York City

GLGi: CMS Reimbursements: Home Health and Skilled Nursing Facilities

GLG Webcasts & Teleconferences

Leading Experts in Biotechnology Patent Experts: Lawyers (US) have not participated in any GLG webcasts.

View All GLG Webcasts & Teleconferences in Legal, Economic & Regulatory Affairs